O Petter Veiby

Years Active: 2018-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Shruti Lal, Neil H Bhola, Bee-Chun Sun, Yuping Chen, Tom Huang, Vivian Morton, Kevin X Chen, Shanghua Xia, Haoyu Zhang, Nehal S Parikh, Qiuping Ye, O Petter Veiby, David I Bellovin, Yuhua Ji
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK Inhibitor. Cancer research communications 3 (9) (2023)
Adnan O Abu-Yousif, Donna Cvet, Melissa Gallery, Bret M Bannerman, Michelle L Ganno, Michael D Smith, Katharine C Lai, Thomas A Keating, Bradley Stringer, Afrand Kamali, Kurt Y Eng, Secil Koseoglu, Andy Zhu, Cindy Q Xia, Melissa Saylor Landen, Maria Borland, Robbie Robertson, Jayaprakasam Bolleddula, Mark G Qian, Jennifer Fretland, O Petter Veiby
Preclinical Antitumor Activity and Biodistribution of a Novel Anti-GCC Antibody-Drug Conjugate in Patient-derived Xenografts. Molecular cancer therapeutics 19 (10) (2020)
Melissa Gallery, Julie Zhang, Daniel P Bradley, Pamela Brauer, Donna Cvet, Jose Estevam, Hadi Danaee, Edward Greenfield, Ping Li, Mark Manfredi, Huay-Keng Loke, Claudia Rabino, Brad Stringer, Mark Williamson, Tim Wyant, Johnny Yang, Qing Zhu, Adnan Abu-Yousif, O Petter Veiby
A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo. PloS one 13 (1) (2018)

O Petter Veiby.css-eqlu8i{font-size:small;padding-left:4px;}